Last reviewed · How we verify
Solo 1 group
At a glance
| Generic name | Solo 1 group |
|---|---|
| Sponsor | ANRS, Emerging Infectious Diseases |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome Sequencing in France
- Hybrid Group Singing (NA)
- Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Medicine Approach (NA)
- Music, Social Attention, and Dementia (NA)
- Pelvic Floor Muscle Training vs. Pilates Exercises for Urinary Incontinence (NA)
- Comparative Effects of Vocal and Breathing Exercises on Respiratory Function and Trunk Stability in Women (NA)
- Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers
- Clarity in Motion Phase-1 Perceptual Study of Speech Intelligibility (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Solo 1 group CI brief — competitive landscape report
- Solo 1 group updates RSS · CI watch RSS
- ANRS, Emerging Infectious Diseases portfolio CI